About

Periodic safety update report single assessments (PSUSAs) are single assessments of related periodic safety update reports (PSURs) for active substances contained in medicines authorised in the European Union (EU). A PSUR is a pharmacovigilance report submitted regularly by a marketing-authorisation holder at defined time points following a medicine's authorisation.

Key facts

Procedure number
PSUSA-00002641-202304
Regulatory outcome
Maintenance

Documents

Rifamycin : List of nationally authorised medicinal products - PSUSA/00002641/202304

English (EN) (174.57 KB - PDF)

First published:
View

Share this page